The operating profits from 2010 to 2012 reported by each of Johnson & Johnson€™s primary business segments are provided below. Sales numbers for each of the segments are provided in BE5€“2 of the Brief Exercises section of this chapter (dollars in millions).

REQUIRED:
a. Which of the segments is the most profitable as a percentage of sales?
b. Which of the segments reports the fastest growth inprofitability?

Transcribed Image Text:

2012 $1,693 $2,096 $2,342 6,075 6,40 7,086 7,187 5,263 8,272 2011 2010 Consumer Pharmaceutical Medical devices